熱門資訊> 正文
TransCode Therapeutics宣布拟议的普通股发行
2024-07-23 04:19
- TransCode Therapeutics (NASDAQ:RNAZ) on Monday announced that it intends to offer to sell shares of its common stock in a best efforts public offering.
- The offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
- Press release.
More on TransCode Therapeutics
- Seeking Alpha’s Quant Rating on TransCode Therapeutics
- Historical earnings data for TransCode Therapeutics
- Financial information for TransCode Therapeutics
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
